Motilal Oswal Financial Services has started coverage on Fortis Healthcare with a 'Buy' rating and a price target of Rs 1,130. The brokerage highlighted strong revenue growth in the company's hospital and diagnostics segments during the first quarter of fiscal year 2027. Investors are now tracking the firm's progress on adding 400 new beds and achieving its margin improvement goals.
Motilal Oswal Financial Services has initiated coverage on Fortis Healthcare, issuing a 'Buy' recommendation with a target price of Rs 1,130. This assessment follows the company’s financial results for the first quarter of the 2027 fiscal year, which showed a steady operational performance across its core healthcare business.
During the quarter ending June 30, 2026, Fortis Healthcare reported consolidated revenue of Rs 2,545 crore, representing a 17.5% increase compared to the same period last year. The hospital segment, which remains the company’s primary revenue generator at 85% of total earnings, saw a 19% year-on-year growth. The diagnostics business also showed signs of improvement, benefiting from better patient volumes and realization per test.
Expansion and Profitability Goals
The company is currently focused on a brownfield expansion strategy, which involves expanding or upgrading existing facilities rather than building new ones from scratch. Management has outlined plans to add over 400 beds throughout the 2027 fiscal year to increase its capacity. While the company achieved an operating EBITDA—a measure of core business profitability—of Rs 568 crore for the quarter, it is aiming to reach a 25% EBITDA margin by the 2028 fiscal year. Successfully balancing this expansion while improving profit margins will be a key area for investors to monitor.
Financial Health and Risks
Fortis Healthcare has also been working on its balance sheet. As of June 30, 2026, the company’s net debt stood at Rs 2,233 crore, a reduction from Rs 2,334 crore recorded on March 31, 2026. This debt reduction is a positive sign for financial stability, though the company continues to manage structural expenses.
Investors should also consider the potential risks associated with the healthcare sector. These include margin pressure arising from rising employee costs and other operational expenses. Additionally, the company faces execution risks related to the timely ramp-up of new bed capacities. Like other players in the industry, Fortis Healthcare must also navigate intense competition in both hospital care and diagnostics, which can impact pricing power and market share.
The final benefit of the current strategy will depend on the company's ability to maintain its growth momentum while managing costs. Key updates to track in the coming quarters include the progress of new bed additions, trends in patient occupancy levels, and the company's ability to sustain margin improvements despite rising operational expenses.